[Use of antiprotein donor plasma for specific detoxication therapy of children with severe burns]

Area of Science:

• Burns, Trauma, and Critical Care
• Immunotherapy and Plasma-Derived Products
• Pediatric Critical Care Medicine

Context:

• Severe burns in children present complex clinical challenges.
• Managing burn-induced immune dysfunction and coagulopathy is critical.
• Standard treatments require adjunctive therapies to improve outcomes.

Purpose:

• To evaluate the therapeutic efficacy of antiproteic donor plasma in severely burned children.
• To assess the impact of antiproteic immunotherapy on clinical, immunologic, and hematologic parameters.
• To determine if antiproteic immunotherapy offers a pronounced therapeutic benefit in pediatric burn patients.

Summary:

• A cohort of 54 severely burned children received antiproteic donor plasma as part of their comprehensive treatment.
• Clinical status, immunologic markers, and hematologic indices were systematically monitored throughout the treatment period.
• A significant positive therapeutic response was observed following the administration of antiproteic immunotherapy.

Impact:

• Antiproteic immunotherapy demonstrates a pronounced therapeutic effect in severely burned pediatric patients.
• This approach may offer a novel strategy for managing severe burn injuries.
• Further research into antiproteic plasma's role in burn management is warranted.